Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jon Giblin
OpenAlex ID:
A5082348909
Current regulatory requirements for assessment of immunogenicity for gene therapy medicinal products
2025
·
Christopher J. Mann
, Jon Giblin
, et al.
·
Cell Reports Medicine
·
7
Current global regulatory landscape for biodistribution & shedding assessment of rAAV gene therapies & recommendations of the IMI ARDAT consortium on future directions
2022
·
, , , , , , , , , , ,
, Natalie Anne Schmidt
, et al.
·
Cell and Gene Therapy Insights
·
2
AAV serotype IVDs for patient selection in gene therapy development: Technical and regulatory considerations by ARDAT consortium
2026
·
Manuela Braun
, Christel Ravesteijn-Verrijt
, et al.
·
Molecular Therapy Advances
Show more works
View as search
Works count:
3
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type
